DNA Vaccine

被引：83

作者：

Cui, Zhengrong ^{[1
]}

机构：

[1] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA

来源：

NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2 | 2005年 / 54卷

关键词：

D O I：

10.1016/S0065-2660(05)54011-2

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The DNA vaccine has proven to be one of the most promising applications in the field of gene therapy. Due to its unique ability to readily induce humoral as well as cellular immune responses, it attracted great interest when the concept was first confirmed in the early 1990s. After thousands of articles related to the DNA vaccine were published, scientists began to realize that although the DNA vaccine is very effective in small animal models, its effectiveness in recent clinical trails is rather disappointing. Therefore, current effort has been shifted to understanding the different performance of the DNA vaccine in mouse and large animal models and on how to transfer the success of the DNA vaccine in small animals to large animals and humans. (C) 2005, Elsevier Inc.

引用

页码：257 / 289

页数：33

共 102 条

[31]

HARDING CV, 1994, J IMMUNOL, V153, P4925

[32] The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 [J].

Hayashi, F ;

Smith, KD ;

Ozinsky, A ;

Hawn, TR ;

Yi, EC ;

Goodlett, DR ;

Eng, JK ;

Akira, S ;

Underhill, DM ;

Aderem, A .

NATURE, 2001, 410 (6832) :1099-1103

[33] Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration [J].

Heikenwalder, M ;

Polymenidou, M ;

Junt, T ;

Sigurdson, C ;

Wagner, H ;

Akira, S ;

Zinkernagel, R ;

Aguzzi, A .

NATURE MEDICINE, 2004, 10 (02) :187-192

[34] A Toll-like receptor recognizes bacterial DNA [J].

Hemmi, H ;

Takeuchi, O ;

Kawai, T ;

Kaisho, T ;

Sato, S ;

Sanjo, H ;

Matsumoto, M ;

Hoshino, K ;

Wagner, H ;

Takeda, K ;

Akira, S .

NATURE, 2000, 408 (6813) :740-745

[35] Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles [J].

Herrmann, JE ;

Chen, SC ;

Jones, DH ;

Tinsley-Bown, A ;

Fynan, EF ;

Greenberg, HB ;

Farrar, GH .

VIROLOGY, 1999, 259 (01) :148-153

[36] Protection against rotavirus infections by DNA vaccination [J].

Herrmann, JE ;

Chen, SC ;

Fynan, EF ;

Santoro, JC ;

Greenberg, HB ;

Wang, SX ;

Robinson, HL .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S93-S97

[37] A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS [J].

Hilleman, MR .

VACCINE, 1998, 16 (08) :778-793

[38]

Ichino M, 1999, J IMMUNOL, V162, P3814

[39]

Iwasaki A, 1997, J IMMUNOL, V158, P4591

[40] Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration [J].

Jones, DH ;

Corris, S ;

McDonald, S ;

Clegg, JCS ;

Farrar, GH .

VACCINE, 1997, 15 (08) :814-817

← 1 2 3 4 5 6 7 8 9 10 →